Gmp Cell Banking Services Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	110 Pages	Coherent Market Insights	June, 2023	CMI18049280

Best Price Guarantee
Price	from $4,500
Length	110 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049280

Gmp Cell Banking Services Market, By Cell Type (Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell Type, Others), By End User, (Biopharmaceutical Companies Contract Manufacturing Organizations), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages.

Cell banking provides a characterized, common starting source for each manufactured lot of product, and assures that an adequate supply of equivalent cells exist for use during the entire lifespan of the product

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisition by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in June 2021, Generate Life Sciences, a life sciences company, announced that it has acquired the Cell Care Group, an international cord blood banking group that comprises cell care in Australia. Cell Care joins Generate's Cord Blood Registry in creating a global network of newborn stem cell (umbilical cord blood and tissue) banks from which to further their collective regenerative medicine research, while also providing Canadian and Australian families with greater access to reproductive and genetic services that help grow and protect healthy families from preconception into adulthood

The increasing adoption of organic growth strategies such as facility expansion by key players in the market to expand their product portfolio is expected to drive market growth over the forecast period. For instance, on April 6, 2023, Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced the completion of two expansions within the company’s mammalian cell facilities. The newly expanded manufacturing capacity includes both upstream and downstream CGMP manufacturing suites and serves as a complement to Avid’s existing Myford facility, providing increased capacity to address the needs of both existing and future mammalian cell business customers

Key features of the study:

This report provides in-depth analysis of the global GMP cell banking services market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global GMP cell banking services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.

Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global GMP cell banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell banking services market

Detailed Segmentation:

Global GMP Cell Banking Services Market, By Cell Type:

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

Global GMP Cell Banking Services Market, By End User:

Biopharmaceutical Companies

Contract Manufacturing Organizations

Global GMP Cell Banking Services Market, By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Company Profiles

WuXi AppTec Group*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Charles River Laboratories International, Inc.,

Eurofins Scientific

Merck KGaA

Lonza Group Ltd.

SGS Ltd.

ViruSure GmbH

Austrianova

Goodwin Biotechnology Inc.

Paragon Bioservices, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market PurviewS: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Cell Type; Market Snapshot, By End User; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Attractiveness Analysis; Market Opportunities; Product Launches; Merger, Acquisition, Collaborations; Regulatory Guideline and Compliances; Key Developments; PEST Analysis; Technology Landscape; PORTER’s Analysis; Pricing Analysis (2022)
4. Global GMP Cell Banking Services Market– COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global GMP Cell Banking Services Market, By Cell Type, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Mammalian; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Microbial; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Insect; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Yeast; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Avian; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Stem Cell Type; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
6. Global GMP Cell Banking Services Market, By End User, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Biopharmaceutical Companies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Contract Manufacturing Organizations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
7. Global GMP Cell Banking Services Market, By Region, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Regions, 2017 – 2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 – 2030, (US$ Million); North Africa; Central Africa; South Africa
8. Competitive Landscape: WuXi AppTec Group*; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Charles River Laboratories International, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Eurofins Scientific; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Lonza Group Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; SGS Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; ViruSure GmbH; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Austrianova; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Goodwin Biotechnology Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Paragon Bioservices, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
9. Section: Research Methodology; About Us; *Browse 31 market data tables and 34 figures on “Global GMP Cell Banking Services Market” - Global forecast to 2030